oddish
Well-Known Member
I wonder if there's any value at all in this.
http://www.cantechletter.com/2015/08/tweed-marijuana-set-to-become-dominant-player-on-bedrocan-acquisition-says-m-partners/
Obviously with this acquisition Tweed becomes the largest producer with the largest variety and the largest distribution network as well as the infrastructure for some pretty big international stuff.
My question though is what the hell they're going to do with 6.5 million grams of cannabis per year.
1 user ~= 4 grams / day (high side of the average)
4 * 30 = 120 grams a month
12 * 120 = 1,440 grams per year. (at $9 a gram that's $12,960)
That's about 4513 patients they can supply. Word on the street is that they have closer to 600 active patients.
Most patients are not using their LP as 100% of their supply, so we could probably assume much closer to 2g/day and that would mean they have supply for over 9,000 patients.
From a business perspective I'm not seeing it. They were already too big and required legalization or international borders to open but now they need both those things and they need them ASAP. I don't see them making this deal with Bedrocan unless they know something - they're dumb at some things, but they're very well connected.
The way I see it, we're either going to see:
I can't wrap my head around this any other way.. the numbers just don't add up.
That said, if they do sell it all at their price point they should be profiting about $39 million a year based on a price of $3 a gram to produce.
Thanks in advance for the "fuck the LPs" and any actual insight that might slip by the hatred.
http://www.cantechletter.com/2015/08/tweed-marijuana-set-to-become-dominant-player-on-bedrocan-acquisition-says-m-partners/
Obviously with this acquisition Tweed becomes the largest producer with the largest variety and the largest distribution network as well as the infrastructure for some pretty big international stuff.
My question though is what the hell they're going to do with 6.5 million grams of cannabis per year.
1 user ~= 4 grams / day (high side of the average)
4 * 30 = 120 grams a month
12 * 120 = 1,440 grams per year. (at $9 a gram that's $12,960)
That's about 4513 patients they can supply. Word on the street is that they have closer to 600 active patients.
Most patients are not using their LP as 100% of their supply, so we could probably assume much closer to 2g/day and that would mean they have supply for over 9,000 patients.
From a business perspective I'm not seeing it. They were already too big and required legalization or international borders to open but now they need both those things and they need them ASAP. I don't see them making this deal with Bedrocan unless they know something - they're dumb at some things, but they're very well connected.
The way I see it, we're either going to see:
- The MMAR and any other "grey areas" disappear. First indications of this are that the CCs that ship by mail have all been warned or fined based on the fact that they are mailing product. I highly doubt this happens, but it's always there as a crazy outcome.
- Legality or decriminalization - this certainly won't come from Health Canada, but the government at some point could roll something out that would effective 10x the customer base overnight.
- Export of extracts / medical studies - now that they can legally create and distribute extracts we need to see where this goes. I imagine we may start to see much more research and international distribution eating into their stock pile.
I can't wrap my head around this any other way.. the numbers just don't add up.
That said, if they do sell it all at their price point they should be profiting about $39 million a year based on a price of $3 a gram to produce.
Thanks in advance for the "fuck the LPs" and any actual insight that might slip by the hatred.
